Plasma N -Glycans as Emerging Biomarkers of Cardiometabolic Risk: A Prospective Investigation in the EPIC-Potsdam Cohort Study.

MLA

Wittenbecher, Clemens, et al. “Plasma N -Glycans as Emerging Biomarkers of Cardiometabolic Risk: A Prospective Investigation in the EPIC-Potsdam Cohort Study.” Diabetes Care, vol. 43, no. 3, Mar. 2020, pp. 661–68. EBSCOhost, https://doi.org/10.2337/dc19-1507.

APA

Wittenbecher, C., Štambuk, T., Kuxhaus, O., Rudman, N., Vučković, F., Štambuk, J., Schiborn, C., Rahelić, D., Dietrich, S., Gornik, O., Perola, M., Boeing, H., Schulze, M. B., & Lauc, G. (2020). Plasma N -Glycans as Emerging Biomarkers of Cardiometabolic Risk: A Prospective Investigation in the EPIC-Potsdam Cohort Study. Diabetes Care, 43(3), 661–668. https://doi.org/10.2337/dc19-1507

Chicago

Wittenbecher, Clemens, Tamara Štambuk, Olga Kuxhaus, Najda Rudman, Frano Vučković, Jerko Štambuk, Catarina Schiborn, et al. 2020. “Plasma N -Glycans as Emerging Biomarkers of Cardiometabolic Risk: A Prospective Investigation in the EPIC-Potsdam Cohort Study.” Diabetes Care 43 (3): 661–68. doi:10.2337/dc19-1507.